Kiniksa Pharmaceuticals reports preliminary 2024 net product revenue of $416.4 million

Stock Information for Capstone Holding Corp.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Capstone Holding Corp.

Capstone Holding Corp. Announces CEO Change
Capstone Holding Corp. Reinstates Tax Benefit Plan
Capstone Holding Corp. Announces Change in Board of Directors
Capstone Holding Corp. Announces Change of Equity Ownership in Diamond Products Holding, LLC
Capstone Holding Corp. Announces CFO Change
Capstone Therapeutics Corp. Announces Results of Annual Meeting
Capstone Holding Corp. Announces Exercise Of Secured Debt And Interest Conversion Option By Majority Shareholder, BP Peptides, LLC
Capstone Therapeutics Corp. Announces Name Change to Capstone Holding Corp.

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.